In this sense, it was observed that differential expression and deposition of ECM proteins, such as collagens, fibronectin, and laminins, by ESCC cell lines was able to decrease the efficacy of different chemotherapeutic agents [38]. The gene discussed is FN1; the disease is esophageal squamous cell carcinoma.